Christopher Porter
Christopher Porter
Ottawa Hospital Research Institute
Verified email at
Cited by
Cited by
A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth
S Bonnet, SL Archer, J Allalunis-Turner, A Haromy, C Beaulieu, ...
Cancer cell 11 (1), 37-51, 2007
An abnormal mitochondrial–hypoxia inducible factor-1α–Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities …
S Bonnet, ED Michelakis, CJ Porter, MA Andrade-Navarro, B Thébaud, ...
Circulation 113 (22), 2630-2641, 2006
Transcriptional dominance of Pax7 in adult myogenesis is due to high-affinity recognition of homeodomain motifs
VD Soleimani, VG Punch, Y Kawabe, AE Jones, GA Palidwor, CJ Porter, ...
Developmental cell 22 (6), 1208-1220, 2012
Gene function in early mouse embryonic stem cell differentiation
KH Sene, CJ Porter, G Palidwor, C Perez-Iratxeta, EM Muro, PA Campbell, ...
BMC genomics 8, 1-21, 2007
GDB: the human genome database
SI Letovsky, RW Cottingham, CJ Porter, PWD Li
Nucleic acids research 26 (1), 94-99, 1998
UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia
A Benyoucef, CG Palii, C Wang, CJ Porter, A Chu, F Dai, V Tremblay, ...
Genes & development 30 (5), 508-521, 2016
Study of stem cell function using microarray experiments
C Perez-Iratxeta, G Palidwor, CJ Porter, NA Sanche, MR Huska, ...
FEBS letters 579 (8), 1795-1801, 2005
Mtf2-PRC2 control of canonical Wnt signaling is required for definitive erythropoiesis
JLM Rothberg, HB Maganti, H Jrade, CJ Porter, GA Palidwor, C Cafariello, ...
Cell Discovery 4 (1), 21, 2018
Targeting the MTF2–MDM2 axis sensitizes refractory acute myeloid leukemia to chemotherapy
HB Maganti, H Jrade, C Cafariello, JL Manias Rothberg, CJ Porter, ...
Cancer discovery 8 (11), 1376-1389, 2018
MLL1 is required for PAX7 expression and satellite cell self-renewal in mice
GC Addicks, CE Brun, MC Sincennes, J Saber, CJ Porter, ...
Nature Communications 10 (1), 4256, 2019
Arab genetic disease database (AGDDB): A population‐specific clinical and mutation database
AS Teebi, SA Teebi, CJ Porter, AJ Cuticchia
Human mutation 19 (6), 615-621, 2002
Managing all those bytes: the Human Genome Project
AJ Cuticchia, MA Chipperfield, CJ Porter, W Kearns, PL Pearson
Science 262 (5130), 47-48, 1993
MaSC: mappability-sensitive cross-correlation for estimating mean fragment length of single-end short-read sequencing data
P Ramachandran, GA Palidwor, CJ Porter, TJ Perkins
Bioinformatics 29 (4), 444-450, 2013
Central mutation databases—a review
CJ Porter, CC Talbot, Jr, AJ Cuticchia
Human mutation 15 (1), 36-44, 2000
CD271+ Cells Are Diagnostic and Prognostic and Exhibit Elevated MAPK Activity in SHH Medulloblastoma
L Liang, L Coudière-Morrison, N Tatari, M Stromecki, A Fresnoza, ...
Cancer Research 78 (16), 4745-4759, 2018
A 19 bp deletion polymorphism adjacent to a dinucleotide repeat polymorphism at the human dopamine β-hydroxylase locus
J Nahmias, MW Burley, S Povey, C Porter, I Craig, J Wolfe
Human Molecular Genetics 1 (4), 286-286, 1992
Report of the fourth international workshop on human chromosome 16 mapping 1995.
NA Doggett, MH Breuning, DF Callen
Cytogenetics and cell genetics 72 (4), 271-293, 1996
StemBase: a resource for the analysis of stem cell gene expression data
CJ Porter, GA Palidwor, R Sandie, PM Krzyzanowski, EM Muro, ...
Stem Cell Assays, 137-148, 2007
An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fate
J Zagozewski, GM Shahriary, LC Morrison, O Saulnier, M Stromecki, ...
Nature Communications 11 (1), 3627, 2020
Sex diversity in proximal tubule and endothelial gene expression in mice with ischemic acute kidney injury
JL Viñas, CJ Porter, A Douvris, M Spence, A Gutsol, JA Zimpelmann, ...
Clinical Science 134 (14), 1887-1909, 2020
The system can't perform the operation now. Try again later.
Articles 1–20